Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $502.09 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $125.00 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $124.94 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $120.59 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $85.70 | 1 | $0 (2019) |
| Allergan Inc. | $45.86 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $85.70 | 1 | GlaxoSmithKline, LLC. ($85.70) |
| 2018 | $120.59 | 1 | Janssen Pharmaceuticals, Inc ($120.59) |
| 2017 | $295.80 | 4 | Shire North American Group Inc ($125.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $85.70 | General |
| Category: VACCINES | ||||||
| 02/15/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug) | Food and Beverage | In-kind items and services | $120.59 | General |
| Category: Neuroscience | ||||||
| 11/02/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 23 | $1,334 | $960.18 |
| 2022 | 1 | 17 | 29 | $1,652 | $955.46 |
| 2021 | 1 | 14 | 35 | $1,680 | $1,048 |
| 2020 | 1 | 24 | 102 | $4,843 | $3,565 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 23 | $1,334 | $960.18 | 72.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 29 | $1,652 | $955.46 | 57.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 35 | $1,680 | $1,048 | 62.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 24 | 102 | $4,843 | $3,565 | 73.6% |
About Dr. Gerry Gaviola, M.D
Dr. Gerry Gaviola, M.D is a Neurology healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881761054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerry Gaviola, M.D has received a total of $502.09 in payments from pharmaceutical and medical device companies, with $85.70 received in 2019. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($502.09).
As a Medicare-enrolled provider, Gaviola has provided services to 71 Medicare beneficiaries, totaling 189 services with total Medicare billing of $6,529. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Morris Plains, NJ
- Active Since 11/30/2006
- Last Updated 02/26/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881761054
Products in Payments
- MYDAYIS (Drug) $125.00
- REXULTI (Drug) $124.94
- INVEGA TRINZA (Drug) $120.59
- BEXSERO (Biological) $85.70
- VRAYLAR (Drug) $45.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.